Using Mendelian randomization to investigate etiologic heterogeneity across renal cell carcinoma subtypes
International Journal of Epidemiology · 14.10.2025 · 54 (6)
DOI: 10.1093/ije/dyaf177 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Epidemiology, online erschienen am 31.10.2025. Verfasst von Timothy D Winter und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genetic Susceptibility, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Mendelian Randomization Analysis, Kidney Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization, Intramural NIH HHS, US Department of Health and Human Services.
Abstract (Originalsprache)
Background
Renal cell carcinoma (RCC) histological subtypes clear cell RCC (ccRCC; >75% of cases) and papillary RCC (papRCC; ∼15%) exhibit distinct molecular and genetic profiles, patient demographics, and prognoses. Previous epidemiologic studies have identified several risk factors for overall RCC, although few have explored differences in etiology across subtypes.
Methods
For this study, we applied two-sample Mendelian randomization (MR) to findings from a genome-wide association study of RCC (27 213 cases, 488 019 controls) to investigate the effects of RCC risk factors with ccRCC (15 507 cases) and papRCC (2103 cases). We also conducted case-only MR analyses contrasting ccRCC and papRCC cases to test for heterogeneity in risk factor effects across subtypes.
Results
MR for overall RCC confirmed associations with obesity, blood pressure, smoking, and several other suspected risk factors. In subtype-specific analyses, we observed stronger associations with ccRCC than for papRCC for anthropometric measures such as body mass index [ccRCC odds ratio (ORccRCC) = 1.58 per standard deviation increase, 95% confidence interval (CI) = 1.50–1.68; papRCC odds ratio (ORpapRCC) = 1.24, 95% CI = 1.07–1.42; Pheterogeneity = 2.7 × 10−4], while stronger associations with papRCC were observed for chronic kidney disease (ORccRCC = 1.07, 95% CI = 0.99–1.15; ORpapRCC = 1.39, 95% CI = 1.16–1.66; Pheterogeneity = 5.42 × 10−5), creatinine-based estimated glomerular filtration rate (ORccRCC = 0.96, 95% CI = 0.92–1.01; ORpapRCC = 0.71, 95% CI = 0.64–0.79; Pheterogeneity = 7.76 × 10−5), and telomere length (ORccRCC = 1.98, 95% CI = 1.93–2.06; ORpapRCC = 2.50, 95% CI = 2.28–2.72; Pheterogeneity = 6.2 × 10−3). Further analysis identified the colocalization of significant RCC risk loci and 20 risk factors along with potential target genes through transcriptomic analysis.
Conclusion
These results highlight the heterogeneous nature of RCC etiology and the importance of considering histologic subtypes in etiologic and genetic studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Genetic Susceptibility, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States.
- Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States.
- Genomic Epidemiology, International Agency for Research on Cancer, Lyon, France.
- Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States.
ORCID-Profile: Diptavo Dutta
Förderung
- World Health Organization
- Intramural NIH HHS
- US Department of Health and Human Services
- Intramural Research Program of the National Cancer Institute, National Institutes of Health
Zitieren
APA
Winter, T. D., Jahagirdar, O., Renal Cancer Genetics Consortium, Johansson, M., Brennan, P., Machiela, M. J., Chanock, S. J., Purdue, M. P., & Dutta, D. (2025). Using Mendelian randomization to investigate etiologic heterogeneity across renal cell carcinoma subtypes. International Journal of Epidemiology, 54(6). https://doi.org/10.1093/ije/dyaf177
Vancouver
Winter TD, Jahagirdar O, Renal Cancer Genetics Consortium, Johansson M, Brennan P, Machiela MJ, et al. Using Mendelian randomization to investigate etiologic heterogeneity across renal cell carcinoma subtypes. International Journal of Epidemiology. 2025;54(6). doi:10.1093/ije/dyaf177
BibTeX
@article{Winter2025,
author = {Winter, Timothy D and Jahagirdar, Om and Renal Cancer Genetics Consortium, Renal Cancer Genetics Consortium and Johansson, Mattias and Brennan, Paul and Machiela, Mitchell J and Chanock, Stephen J and Purdue, Mark P and Dutta, Diptavo},
title = {Using Mendelian randomization to investigate etiologic heterogeneity across renal cell carcinoma subtypes},
journal = {International Journal of Epidemiology},
year = {2025},
volume = {54},
number = {6},
doi = {10.1093/ije/dyaf177}
}
EUVIMED